Efficacy & Clinical Studies On TMS Therapy

Learn more from the professionals in the medical industry about TMS Therapy.

Take the Self Assessment


The STAR*D Study is the largest trial ever done on psychotropic medications. Over 4,000 patients were studied over seven years looking at their remission rates for medicines.

  • First-line treatment produced the 27.5% chance of remission
  • Second-line treatment produced a 21.2% chance of remission
If you failed to manage the third-line treatment medication, it produced a 16.2% chance of remission.  If participants failed on three medications, the fourth medicine produced a 6.9% chance of remission. If a script were handed across the table, and a doctor were to tell the patient that because they're on their fourth medication it has only a 7% chance of working they would probably ask if there were any other options...which there are., like TMS Therapy.
Patient Presentation New Logo

Download Presentation

Clinical Studies


The New England Comparative Effectiveness Public Advisory Council Public Meeting – December 9, 2011

Nonpharmacologic Interventions for Treatment-Resistant Depression: Supplementary Data and Analyses to the Comparative Effectiveness Review of the Agency for Healthcare Research and Quality

FINAL MEETING REPORT – December 22, 2011 Completed by:
The Institute for Clinical and Economic Review

Click To Read The Full Report >>


A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

David L. Dunner, MD; Scott T. Aaronson, MD; Harold A. Sackeim, PhD; Philip G. Janicak, MD; Linda L. Carpenter, MD; Terrence Boyadjis, MD;
David G. Brock, MD; Dafna Bonneh-Barkay, PhD; Ian A. Cook, MD;
Karl Lanocha, MD; H. Brent Solvason, MD, PhD; and Mark A. Demitrack, MD

Click To Read The Full Report >>